7 news items
Actinium Pharmaceuticals (ATNM) Leads Biotech Innovation Amid Economic Uncertainty
ABBV
ATNM
AZN
19 Apr 24
underscore the high "scarcity value" of companies like Actinium, making ATNM a compelling investment candidate amidst the current M&A trend
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
ATNM
AZN
BMY
18 Apr 24
billion, targeting its portfolio of Lu-177 and Ac-225 based therapies in October 2023. These acquisitions underscore the high "scarcity value
Actinium Pharmaceuticals (ATNM) Garners Attention with Clinical Successes and Strategic Market Moves Amid Growing Radiopharma Interest
ATNM
AZN
BMY
17 Apr 24
of RayzeBio, highlighting the high demand and "scarcity value" of innovative companies like Actinium. Currently, ATNM is trading at less than 8
Actinium Pharmaceuticals (ATNM) Spearheading the Future of Oncology with Iomab-ACT's Innovative Clinical Trial
ATNM
AZN
BMY
27 Mar 24
its scarcity value and technological edge, making it a compelling target for companies vying for dominance in next-generation cancer therapies
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma Acquisition Wave
ARGX
ATNM
AZN
26 Mar 24
. In this landscape, Actinium's strategic initiative underscores its scarcity value and technological edge, making it a compelling target for companies vying
nka4tyuhw54wflx52n6vofo3102vtbigr
ATNM
AZN
BMY
25 Mar 24
in the space, places a potential “scarcity value” on Actinium, the firm argues.
In conclusion, as Vertex
wanyr33mqrl82qd 3dnl9i
ARGX
ATNM
AZN
22 Mar 24
, places a potential “scarcity value” on Actinium, the firm argues.
In conclusion, as JPMorgan's
- Prev
- 1
- Next